Forsta AP Fonden lifted its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 66.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 46,420 shares of the biopharmaceutical company's stock after buying an additi